3083 related articles for article (PubMed ID: 765453)
1. Immunotherapy of malignant disease (Part 2).
MacGregor AB; Falk RE
J R Coll Surg Edinb; 1976 Jan; 21(1):43-9. PubMed ID: 765453
[No Abstract] [Full Text] [Related]
2. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
3. Immunology of malignancy.
Kaufman JR
J Indiana State Med Assoc; 1975 Aug; 68(8):712-5. PubMed ID: 1095658
[No Abstract] [Full Text] [Related]
4. [Immunotherapy of malignant melanomas].
Macher E
Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
[No Abstract] [Full Text] [Related]
5. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
Southam CM
J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
[No Abstract] [Full Text] [Related]
6. [Immunotherapy of malignant tumors].
Adolphs HD
Med Klin; 1975 Feb; 70(7):255-66. PubMed ID: 1091835
[No Abstract] [Full Text] [Related]
7. Immunotherapy: new hope for the cancer patient.
Costanzi JJ; Goldstein AL
Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856
[No Abstract] [Full Text] [Related]
8. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
9. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
Schöpf E
Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
[No Abstract] [Full Text] [Related]
10. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
Spitler LE; Wong P; Sagebiel R
Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
[TBL] [Abstract][Full Text] [Related]
11. [Problems of cancer immunotherapy (author's transl)].
Gericke D
MMW Munch Med Wochenschr; 1977 Nov; 119(46):1497-1500. PubMed ID: 414081
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of cancer].
Gil Extremera B
Rev Clin Esp; 1976 Aug; 142(3):281-91. PubMed ID: 788067
[No Abstract] [Full Text] [Related]
13. [Current status of immunotherapy in neoplasms].
Diaz-Rubio García E
Rev Clin Esp; 1975 Dec; 139(6):487-96. PubMed ID: 766120
[No Abstract] [Full Text] [Related]
14. [Tumor immunology].
Milas L; Silobrcić V
Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
[No Abstract] [Full Text] [Related]
15. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
16. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
Kristensen E
Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
[No Abstract] [Full Text] [Related]
17. Immunotherapy for malignant disease.
Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
[No Abstract] [Full Text] [Related]
18. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
19. Improving the body's anticancer system.
Kent S
Geriatrics; 1980 Feb; 35(2):122-9. PubMed ID: 7356587
[No Abstract] [Full Text] [Related]
20. Immunotherapy in childhood cancer.
Leventhal BG
Pediatr Ann; 1978 Aug; 7(8):570-4. PubMed ID: 693076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
